Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,160.7
18.5 (0.59%)

 

  • STI Straits Times Index
    3,160.7
    18.5 (0.59%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,500.5
    10.4 (0.70%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,862.4
    41.5 (0.15%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,013.1
    -18.2 (-0.60%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,605.4
    -781.3 (-3.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,792.2
    -14.8 (-0.26%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 793.5M
  • Value: 902.3M
  • Rise: 158
  • Fall: 139
  • Unch: 517

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.188+0.010
AusGroup^0.044+0.001
Genting Sing0.865-0.005
IPS Securex0.080+0.007
Broadway Ind^0.085+0.010
Trendlines0.117+0.008
ESR-REIT0.550+0.005
YZJ Shipbldg SGD1.010+0.010
OEL0.025+0.001
MarcoPolo Marine0.021+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,221.3 -355.3
HSI 26,912.0 +91.2
HSCEI 10,584.5 +16.2
Jakarta 5,792.3 -14.7
Nikkei 225 22,605.4 -781.3
SSE Comp 3,013.1 -18.2
Shanghai A 3,157.4 -19.0
Shanghai B 242.6 -1.9
KOSPI 2,103.6 +24.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 25 Feb 2020 16:07
Last (SGD): 0.094 Change: -0.003 High: 0.098 Remarks: -
Change (%): -3.09 Low: 0.093
Open 0.094 Yesterday's Close 0.097
Buy Price 0.093 Sell Price 0.094
Buy Volume ('000) 639.5 Sell Volume ('000) 450.1
Cumulative Volume ('000) 12,312.6 Cumulative Value 1,177,516
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00227 Trailing EPS (SGD) e 0.00234 NAV (SGD) b 0.1548
PE a 41.410 Trailing PE f 40.159 Price / NAV b 0.6072
Dividend (SGD) d - Cash In Hand (SGD) g 0.0045 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 20.889 Treasury Shares h -
Beta - 75 Daysi -9.794 R-Squared - 75 Days(%)i 16.73 Market Cap (M) 51.645
Beta - 500 Daysi -1.171 R-Squared - 500 Days (%)i 1.52 Enterprise Value (M) 96.455
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 94.7898 6-Month VWAP 0.112 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 51.645 41.410 40.159 0.6072 -
Industry Medical & Biotechnology SGX 1,031.093 20.826 19.978 1.3675 1.877
Medical Specialties SGX 825.472 48.271 48.381 5.0029 0.690
Index FTSE ST Catalist Index SGX 72.578 30.063 88.683 0.8606 2.343
Local Peer Top Glove SGX 4,766.042 39.108 39.105 5.9730 0.707
Local Peer Biolidics SGX 52.138 - - 4.8315 -
Local Peer UG Healthcare SGX 47.062 18.779 23.138 1.1080 1.064
Local Peer Yunnan Energy SGX 43.794 - - 0.8923 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 149,575.062 63.568 40.801 4.8113 1.362
Global Peer MEDTRONIC PLC NYSE 149,296.967 32.239 28.090 2.8817 1.868
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 129,580.242 44.105 35.060 4.3666 0.226
Global Peer DANAHER CORP NYSE 109,068.310 41.144 43.824 3.8041 0.412
Global Peer STRYKER CORP NYSE 80,739.641 22.724 38.761 6.3043 0.895
Global Peer BECTON DICKINSON & CO NYSE 67,936.972 - 90.946 3.2046 -
Global Peer INTUITIVE SURGICAL INC NASDAQ 67,290.437 59.660 48.786 8.1428 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 57,258.126 34.266 12.183 - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,197.305 65.352 45.083 11.3775 -
Global Peer BAXTER INTERNATIONAL INC NYSE 45,710.079 28.147 28.894 5.8513 0.819
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), DEXCOM INC (NASDAQ), RESMED INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), WATERS CORP (NYSE), HOLOGIC INC (NASDAQ), INSULET CORPORATION (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), WEIGAO GROUP (HKEx), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HARTA (Bursa), ICU MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), NEVRO CORP (NYSE), WRIGHT MEDICAL GROUP NV (NASDAQ), NUVASIVE INC (NASDAQ), NEOGEN CORP (NASDAQ), TOPGLOV (Bursa), LIVANOVA PLC (NASDAQ), QUIDEL CORP (NASDAQ), CANTEL MEDICAL CORP (NYSE), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), IRHYTHM TECHNOLOGIES INC (NASDAQ), AK MEDICAL (HKEx), MERIT MEDICAL SYSTEMS (NASDAQ), MICROPORT (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), BIOTELEMETRY INC (NASDAQ), ATRICURE INC (NASDAQ), AVANOS MEDICAL INC (NYSE), SILK ROAD MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), NANOSONICS LIMITED (ASX), ATRION CORP (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), INMODE LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), CAREDX INC (NASDAQ), VENUS MEDTECH-B (HKEx), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), NATUS MEDICAL INC (NASDAQ), INOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CIRC (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), LIFETECH SCI (HKEx), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), HESKA CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), SI BONE INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), SUPERMX (Bursa), SURMODICS INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ZYNEX INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), SEASPINE HOLDINGS CORP (NASDAQ), YESTAR HEALTH (HKEx), ALPHATEC HLDGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), ORASURE TECHNOLOGIES INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CUTERA INC (NASDAQ), CORMEDIX INC (NYSE American), UTAH MEDICAL PRODUCTS (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), INVACARE CORP (NYSE), IRADIMED CORP (NASDAQ), GOLDEN MEDITECH (HKEx), ACCURAY INCORPORATED (NASDAQ), MISONIX INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), STEREOTAXIS INC (NYSE American), SIENTRA INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PROFOUND MED CORP (NASDAQ), PW MEDTECH (HKEx), VENUS CONCEPT INC (NASDAQ), KDL MEDICAL (HKEx), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), CYTOSORBENTS CORP (NASDAQ), TELA BIO INC (NASDAQ), SOLITON INC (NASDAQ), VAPOTHERM INC (NYSE), MODERN DENTAL (HKEx), DERMTECH INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INTRICOM CORP (NASDAQ), FONAR CORP (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PAVMED INC (NASDAQ), ALPHA PRO TECH (NYSE American), RESAPP HEALTH LIMITED (ASX), ELECTROMED INC (NYSE American), YUNNAN ENERGY (HKEx), BIOSIG TECHNOLOGIES INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), COMPUMEDICS (ASX), CLEARPOINT NEURO INC (NASDAQ), ONCOCYTE CORP (NYSE American), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), NEPHROS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), SDI LTD (ASX), CONFORMIS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), CYCLOPHARM LIMITED (ASX), NEURONETICS INC (NASDAQ), KELFRED (HKEx), APOLLO ENDOSURGERY INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), VINCENT MED (HKEx), OVENTUS MEDICAL LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), MOTUS GI HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), IRIDEX CORP (NASDAQ), RESONANCE HEALTH LTD (ASX), DAXOR CORP (NYSE American), IMMUCELL CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), IMPEDIMED LIMITED (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), MICRO-X LTD (ASX), ELECTROCORE INC (NASDAQ), CELSION CORPORATION (NASDAQ), RESPIRI LTD (ASX), NEOVASC INC (NASDAQ), LIFE HEALTHCARE (HKEx), USCOM LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), BIOMERICA INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), LBT INNOVATIONS LTD (ASX), AETHLON MEDICAL INC (NASDAQ), BIOLASE INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), THERMOGENESIS HOLDINGS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), RA MEDICAL SYSTEMS INC (NYSE), ENDOLOGIX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), DIMERIX LTD (ASX), LKL (Bursa), NEUROTROPE INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CHECK-CAP LTD (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), CARDIEX LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), CYANOTECH CORP (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), AVINGER INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ADHERIUM LIMITED (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), OPTISCAN IMAGING (ASX), REWALK ROBOTICS LTD (NASDAQ), DYNATRONICS CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), TENAX THERAPEUTICS INC (NASDAQ), INSPIREMD INC (NYSE American), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), HUAKANG BIOMED (HKEx), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ANALYTICA (ASX), VIVEVE MEDICAL INC (NASDAQ), DIGIRAD CORP (NASDAQ), STHAI (SET), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), NEUROMETRIX INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), DORSAVI LTD (ASX), METALICITY LIMITED (ASX), MEDIGARD LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.019
-16.81 %
10 Days --0.017
-15.32 %
20 Days --0.010
-9.62 %
Medium Term Return 3 Months -+0.057
+154.05 %
6 Months -+0.066
+235.71 %
1 Year -+0.066
+235.71 %
Long Term Return 2 Years -+0.048
+104.35 %
3 Years -+0.044
+88.00 %
5 Years -+0.043
+84.31 %
Annualised Return Annualised --
+13.01 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.022 - 0.210 Change From 1 Year Low +0.072 % Change From 1 Year Low (%) +327.27
Change From 1 Year High -0.116 % Change From 1 Year High (%) -55.24
2 Years Range 0.022 - 0.210 Change From 2 Years Low +0.072 % Change From 2 Years Low (%) +327.27
Change From 2 Years High -0.116 % Change From 2 Years High (%) -55.24
5 Years Range 0.022 - 0.210 Change From 5 Years Low +0.072 % Change From 5 Years Low (%) +327.27
Change From 5 Years High -0.116 % Change From 5 Years High (%) -55.24
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) -62.55 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
24 Feb 2020 0.102 0.105 0.095 0.097 41,386,900 0.1005
21 Feb 2020 0.095 0.102 0.095 0.097 35,707,400 0.0990
20 Feb 2020 0.099 0.100 0.093 0.096 25,686,200 0.0972
19 Feb 2020 0.106 0.108 0.090 0.098 60,777,200 0.0986
18 Feb 2020 0.104 0.107 0.100 0.104 57,820,200 0.1031
17 Feb 2020 0.113 0.118 0.111 0.113 41,558,200 0.1140
14 Feb 2020 0.118 0.118 0.109 0.113 45,123,200 0.1140
13 Feb 2020 0.112 0.123 0.111 0.115 156,317,300 0.1165
12 Feb 2020 0.109 0.115 0.106 0.111 69,699,500 0.1123
11 Feb 2020 0.109 0.113 0.103 0.110 93,007,600 0.1084
10 Feb 2020 0.116 0.126 0.105 0.111 263,175,900 0.1173
07 Feb 2020 0.083 0.112 0.081 0.103 288,624,800 0.0999
06 Feb 2020 0.100 0.104 0.076 0.076 105,650,700 0.0890
05 Feb 2020 0.115 0.120 0.097 0.101 147,713,600 0.1058
04 Feb 2020 0.128 0.133 0.115 0.120 105,063,400 0.1225
03 Feb 2020 0.122 0.140 0.117 0.126 180,919,700 0.1290
31 Jan 2020 0.165 0.177 0.110 0.112 217,642,800 0.1337
30 Jan 2020 0.196 0.197 0.171 0.173 162,743,000 0.1828
29 Jan 2020 0.185 0.210 0.185 0.196 233,096,200 0.1937
28 Jan 2020 0.114 0.172 0.114 0.172 325,269,700 0.1427
24 Jan 2020 0.107 0.109 0.101 0.104 72,671,100 0.1052
23 Jan 2020 0.104 0.105 0.091 0.105 102,893,400 0.1001
Summary
Current 2 Weeks
(11 Feb 2020 to 24 Feb 2020)
0.109 0.123 0.090 0.097 627,083,700 -
Previous 2 Weeks
(28 Jan 2020 to 10 Feb 2020)
0.114 0.172 0.090 0.111 2,029,899,800 -
4 Weeks from
(27 Dec 2019 to 24 Jan 2020)
0.038 0.123 0.037 0.104 737,475,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.